Alok (Pron: Ah-Loke) Sonig is CEO, US Generics and Global Head, Generics R&D and Biosimilars of Lupin, Inc.
With over 23 years of experience in the pharmaceutical industry, Alok has previously served as the CEO of Developed Markets (U.S., Canada, Europe and Japan) at Dr. Reddy's Laboratories. Prior to Dr. Reddy's Laboratories, he spent over 15 years at Bristol-Myers Squibb, where he held several positions of increasing responsibilities in General Management, Global Strategy, and Marketing.
Alok holds a Bachelor's of Engineering from Punjab Engineering College in India and an MBA from American University in Washington, DC.